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It is widely appreciated that T cells increase glyco-
lytic flux during activation, but the role of mitochon-
drial flux is unclear. Here, we have shown that
mitochondrial metabolism in the absence of glucose
metabolism is sufficient to support interleukin-2
(IL-2) induction. Furthermore, we used mice with
reduced mitochondrial reactive oxygen species
(mROS) production in T cells (T-Uqcrfs/ mice) to
show that mitochondria are required for T cell activa-
tion to produce mROS for activation of nuclear factor
of activated T cells (NFAT) and subsequent IL-2
induction. These mice could not induce antigen-
specific expansion of T cells in vivo, but Uqcrfs1/
T cells retained the ability to proliferate in vivo
under lymphopenic conditions. This suggests that
Uqcrfs1/ T cells were not lacking bioenergetically
but rather lacked specific ROS-dependent signal-
ing events needed for antigen-specific expansion.
Thus, mitochondrial metabolism is a critical compo-
nent of T cell activation through the production of
complex III ROS.
INTRODUCTION
T cells orchestrate the adaptive immune response and are crit-
ical for pathogen-specific defense and immunological memory.
When quiescent naive T cells are stimulated by antigen, they
undergo an activation program that initiates rapid proliferation
and primes them for differentiation to effector subtypes. Activa-
tion requires ligation of both the T cell receptor (TCR) and the
costimulatory molecule CD28. The TCR and CD28 then initiate
integrated phosphorylation-based signaling cascades that result
in the activation of transcription factors, including nuclear factor
of activated T cells (NFAT), activator protein 1 (AP-1), and nuclear
factor of kappa light chain enhancer in B cells (NF-kB), topromote expression of proteins that drive T cell activation,
such as interleukin 2 (IL-2) (Smith-Garvin et al., 2009).
A central part of the T cell activation program is a change in
cellular metabolism. Proliferating cells have vastly different
metabolic requirements than quiescent cells; although quiescent
cells only need metabolism to support housekeeping functions
and trafficking throughout the body, proliferating cells need to
produce more ATP for enhanced activity, intermediates for
biosynthesis, and signaling molecules to propagate anabolic
metabolism.
The most dramatic change in T cell metabolism upon activa-
tion is a marked increase in glucose metabolism, which appears
to be regulated by the PI3K and Akt pathway and the transcrip-
tion factorsMyc and ERRa (Frauwirth et al., 2002;Michalek et al.,
2011; Wang et al., 2011). Activated T cells take up large amounts
of glucose while simultaneously producing lactate. This has led
to the widespread conceptual idea that activated T cells are
primarily glycolytic despite ample oxygen supply and engage
in a process termed aerobic glycolysis (Jones and Thompson,
2007; Krauss et al., 2001; Pearce, 2010; Wang et al., 1976).
However, although glycolysis might be important as a rapid
source of ATP and as a conduit to the pentose phosphate
pathway to generate NADPH and nucleotides, it is insufficient
to provide the full complement of factors needed for cell prolifer-
ation. Interestingly, T cells also increase glutamine metabolism
upon activation, and glutamine is required for T cell proliferation
(Carr et al., 2010). Glutamine is primarily a mitochondrial sub-
strate in that it can fuel the mitochondrial tricarboxylic acid
(TCA) cycle through conversion to a-ketoglutarate in a process
called glutaminolysis. Glutaminolysis is particularly important in
proliferating cells in which TCA-cycle intermediates are continu-
ally depleted for use in biosynthetic reactions (DeBerardinis
et al., 2007). This suggests that mitochondrial metabolism might
play an important role in T cell activation.
In addition to supporting biosynthesis, mitochondria are major
sources of reactive oxygen species (ROS). Superoxide is gener-
ated at complexes I, II, and III of the mitochondrial electron
transport chain (ETC) (Turrens, 2003). Complexes I and II emit
superoxide into the mitochondrial matrix, where it is converted
to hydrogen peroxide (H2O2) by superoxide dismutase 2Immunity 38, 225–236, February 21, 2013 ª2013 Elsevier Inc. 225
Figure 1. Mitochondrial Metabolism Is Sufficient to Support CD4+ T Cell Activation
(A and B) The extracellular acidification rate (ECAR) (A) and mitochondrial oxygen consumption rate (mitoOCR) (B) of freshly isolated CD4+ T cells and 24 hr
CD3- and CD28-stimulated CD4+ T cells (n = 3 ± SEM). *p < 0.05, **p < 0.01.
(C) Cell viability of CD4+ T cells cultured in indicated media with and without CD3 and CD28 stimulation at 24 hr (n = 3 ± SEM).
(D) Surface expression of CD69 and CD25 of CD4+ T cells cultured in indicated media at 24 hr (n = 3 ± SEM).
(E) Relative IL-2 mRNA expression, normalized to ML-19 expression, of CD4+ T cells cultured in indicated media at 24 hr (n = 3 ± SEM). *p < 0.05.
(F) Cell growth (48 hr) and cell proliferation (96 hr) of CD4+ T cells cultured in indicated media (n = 3).
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Mitochondrial ROS Regulate T Cell Activation(SOD2). This H2O2 can then freely diffuse across the mitochon-
drial membranes into the intermembrane space and cytosol.
Of note, complex III emits superoxide into both the matrix and
the intermembrane space; intermembrane-space superoxide
can access the cytosol through voltage-dependent anion chan-
nels without prior conversion to H2O2 (Han et al., 2003; Muller
et al., 2004; Murphy, 2009). We and others have shown that
mitochondrial ROS (mROS), particularly complex III ROS, can
function as signaling intermediates (Byun et al., 2008; Schieke
et al., 2008; Tormos et al., 2011; Weinberg et al., 2010). Interest-
ingly, previous studies have shown that ROS are generated
within 15 min of TCR cross-linking (Devadas et al., 2002) and
that treatment of mice with panantioxidants reduces T cell
expansion (Laniewski and Grayson, 2004; Piganelli et al.,
2002). However, the source of these ROS and whether they
are necessary for T cell activation have not previously been
well defined.
Here, we report a critical role for mitochondrial metabolism in
T cell activation. Mitochondrial oxygen consumption increased
during T cell activation, and fueling mitochondria was sufficient
to support T cell activation. mROS also increased during T cell
activation, and this induction was regulated by calcium influx.
Using mice with T-cell-specific reduction of Rieske iron sulfur
protein (RISP), a subunit of mitochondrial complex III, we226 Immunity 38, 225–236, February 21, 2013 ª2013 Elsevier Inc.showed that mitochondrial metabolism, specifically mitochon-
drial complex III ROS production, is essential for T cell activation
both in vitro and in vivo.
RESULTS
Mitochondrial Metabolism Can Support CD4+ T Cell
Activation
In accordance with previous reports, we found that CD4+ T cells
increased their extracellular acidification rate (ECAR), a lactic-
acid-secretion measure indicative of the rate of glycolysis,
4-fold after 24 hr of CD3 and CD28 stimulation (Figure 1A).
This phenomenon has historically eclipsed a role for mitochon-
dria in T cell activation, yet we found that the mitochondrial
oxygen consumption rate (mitoOCR) also increased after stimu-
lation (Figure 1B). To determine whether increased glycolysis or
glucosemetabolism is functionally important for T cell activation,
we cultured CD4+ T cells inmediamadewith dialyzed serumwith
10 mM glucose added or omitted. In the absence of glucose,
nearly all unstimulated and CD3- and CD28-stimulated cells
were dead after 24 hr (Figure 1C). Interestingly, cell viability could
be recovered by the addition of sodium pyruvate (Figure 1C),
which bypasses upstream glucosemetabolism and directly fuels
the mitochondrial TCA cycle (Figure S1A, available online). CD4+
Immunity
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metabolism, as shown by the fact that they were sensitized to
cell death by treatment with mitochondrial complex I and
complex III inhibitors rotenone and antimycin (Figure S1B).
Furthermore, pyruvate did not rescue glucose-deprivation-
induced cell death by supporting glucose metabolism through
gluconeogenesis, given that the phosphoenolpyruvate carboxy-
kinase inhibitor, 3-mercaptopropionic acid (3-MPA) had no
effect on cell death (Figure S1C). Thus, mitochondrial metabo-
lism was sufficient to support CD4+ T cell viability. Of note, the
presence of glutamine was insufficient to maintain T cell viability
in the absence of glucose (Figure 1C); however, the downstream
metabolite of glutaminolysis, a-ketoglutarate (the cell-perme-
able form is dimethylketoglutarate [DMK]), partially rescued cell
viability (Figure S1D). This suggests that glutamine did not
support viability in the absence of glucose because it failed to
be converted to a-ketoglutarate, a TCA-cycle intermediate.
Wellen et al. similarly describe this effect and suggest that
glucose is required for glycosylation events necessary for
glutamine uptake (Wellen et al., 2010).
Importantly, mitochondrial metabolism was also sufficient to
support CD4+ T cell activation, given that cells cultured with
pyruvate or DMK in the absence of glucose upregulated surface
expression of the activation markers CD69 and CD25 (Figure 1D
and Figures S1E and S1F) and induced IL-2 mRNA (Figure 1E
and Figure S1G) after CD3 and CD28 stimulation. Glutamine
was required for full induction of IL-2 in glucose media but was
not necessary for full induction of IL-2 in pyruvate media (Fig-
ure 1E). This is most likely because in the absence of glucose,
pyruvate is not converted to lactate as a result of a lack of cyto-
solic NADH generated by glycolysis and is instead fully available
for use in the TCA cycle. In the presence of glucose, NADH is
generated by glycolysis, allowing for lactate dehydrogenase to
convert pyruvate to lactate and NAD+, reducing pyruvate avail-
ability to the TCA cycle and necessitating additional carbon
influx through glutaminolysis (Figure S1A). The requirement of
glutamine for full induction of IL-2 in glucose media might
support the idea that mitochondrial metabolism is also required
for T cell activation. Nevertheless, these data clearly suggest that
glucose metabolism is only required for T cell activation inso-
much as it can provide pyruvate to fuel the mitochondria. As
previously reported, both glucose and glutamine were necessary
for CD4+ T cell growth and proliferation after CD3 and CD28
stimulation (Figure 1F). This was expected given that glucose
and glutamine are required for biosynthesis through the pentose
phosphate, hexosamine, and glutaminolysis pathways (DeBer-
ardinis et al., 2008; Lunt and Vander Heiden, 2011; Wellen
et al., 2010). The unexpected aspect of these results is that mito-
chondrial metabolism alone was sufficient to support T cell
viability and signaling for activation prior to cell growth and
proliferation.
CD3-Dependent Calcium Influx Induces mROS, which
Are Required for CD4+ T Cell Activation
A consequence of mitochondrial metabolism is production of
mROS. Using CD4+ T cells isolated from transgenic mice ex-
pressing a mitochondrial-targeted redox-sensitive GFP (mito-
roGFP) (Guzman et al., 2010), we found that mROS spiked
10 min after stimulation and were maintained at a higher levelthan baseline through 120min (Figure 2A). To determine whether
these ROS are functionally important for T cell activation, we
treated CD4+ T cells with the mitochondrial-targeted antioxidant
mitovitamin E (MVE). MVE is targeted to the mitochondria by
covalent coupling to a triphenylphosphonium cation (TPP),
which served as a control compound (Dhanasekaran et al.,
2005). MVE attenuated IL-2 induction (Figure 2B) without
affecting cell viability (Figure S2), indicating that mROS are
necessary for T cell activation.
Interestingly, mROS induction was mediated by CD3 stimula-
tion, not CD28 stimulation (Figure 2C). Because CD3 activation
leads to rapid influx of calcium, we predicted that this calcium
influx could regulate mROS induction, which also occurs early.
Indeed, we found that influx of extracellular calciumwas required
for mROS induction, given that chelation of extracellular calcium
by EDTA or inhibition of the calcium-release-activated calcium
(CRAC) channel by BTP2 was sufficient to inhibit the mROS
response (Figure 2D). Furthermore, influx of calcium into mito-
chondria was also required for mROS induction, as shown by
the fact that Ruthenium Red and Ru360 also inhibited the
mROS response after CD3 and CD28 stimulation (Figure 2D). It
is known that several TCA-cycle enzymes are regulated by
calcium (McCormack et al., 1990); thus, calcium influx into
mitochondria might increase TCA cycling, electron transport,
and, consequently, mitochondrial membrane potential, which
is associated with increased mROS production. In support of
this, we found that reduction of mitochondrial membrane poten-
tial by FCCP diminished IL-2 induction, and this defect was
partially rescued by treatment with galactose oxidase (GaO)
and 500 mM galactose (Gal) (Figure 2E). In the presence of Gal
in the culture media, GaO produces H2O2, which can freely
diffuse into the cell (Wang et al., 1998). Thus, calcium influx
through CRAC channels and subsequent calcium influx into
mitochondria increase mROS production most likely by
increasing mitochondrial membrane potential, and this induction
of mROS is required for T cell activation.
Mitochondrial Complex III ROS Are Required for CD4+
T Cell Activation
Previous reports have indicated that themitochondrial complex I
inhibitor rotenone reduces CD4+ IL-2 induction, as well as CD8+
T cell blasting, proliferation, and cytokine production (Kaminski
et al., 2010; Yi et al., 2006); however, inhibition of complex I coor-
dinately reduces activity of the downstream complex III (Fig-
ure S3). Previous work in our laboratory indicated that complex
III is an important source of ROS for cell signaling (Bell et al.,
2007; Tormos et al., 2011; Weinberg et al., 2010). Thus, we
hypothesized that complex III is the major site of mROS produc-
tion in CD4+ T cells. To test this, we sought to conditionally delete
Uqcrfs1 in T cells inmice.Uqcrfs1 is the gene that encodes RISP,
a complex III subunit that is required for transfer of electrons
downstream of complex III and complex III ROS production
(Snyder et al., 1999). Mice that possess Uqcrfs1 flanked by
loxP sites (Uqcrfs1fl/fl) were crossed to mice that express Cd4-
cre. Thymic cellularity (Figure 3A) and proportions and numbers
of DN, DP, and SP cells (Figure 3B) were normal in Uqcrfs1fl/fl;
Cd4-cre mice, which permitted analysis of peripheral CD4+
T cells. CD4+ T cells isolated from Uqcrfs1fl/fl; Cd4-cre mice
had little detectable RISP by immunoblot (hereafter calledImmunity 38, 225–236, February 21, 2013 ª2013 Elsevier Inc. 227
Figure 2. CD3-Dependent Calcium Influx Induces mROS, Required for T Cell Activation
(A) mROS productionmeasured by percent oxidizedmito-roGFP probe of CD4+ T cells isolated frommito-roGFP transgenicmice after CD3 andCD28 stimulation
(n = 3 ± SEM). *p < 0.05.
(B) Relative IL-2 mRNA expression, normalized to ML-19 expression, of CD4+ T cells cultured with mitovitamin E (MVE) and triphenylphosphonium cation (TPP)
(1.5 mM each) at 8 hr (n = 3 ± SEM). **p < 0.01.
(C)mROSproductionmeasuredbypercentoxidizedmito-roGFPprobeofCD4+Tcells isolated frommito-roGFP transgenicmiceafter indicatedstimulation (n=3±
SEM). A number sign indicates a significant difference from column 1, and an asterisk indicates a significant difference from column 2. *p < 0.05, #p < 0.05.
(D)mROS productionmeasured by percent oxidizedmito-roGFP probe of CD4+ T cells isolated frommito-roGFP transgenicmice after CD3 andCD28 stimulation
with calcium inhibitors (1 mM EDTA, 200 nM BTP2, 5 mm Ruthenium Red [RR], and 5 mm Ru360) (n = 3 ± SEM). **p < 0.01.
(E) Relative IL-2 mRNA expression, normalized to ML-19 expression, of CD4+ T cells cultured with FCCP (1 mM) and GaO (0.045 U/ml) and Gal (500 mM) at 4 hr
(n = 3 ± SEM). **p < 0.01.
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Mitochondrial ROS Regulate T Cell ActivationUqcrfs1/ T cells or T-Uqcrfs1/ mice), whereas non-T-
cell splenocytes possessed normal amounts (Figure 3C).
T-Uqcrfs1/ mice possessed similar numbers of total spleno-
cytes, B cells, and macrophages as Uqcrfs1fl/fl littermate
controls (hereafter called WT) but showed a trend toward fewer
CD4+ T cells and significantly fewer CD8+ T cells in the periphery
(Figure 3D).
As expected, compared with WT T cells, Uqcrfs1/ CD4+
T cells produced significantly reduced amounts of activation-
induced mROS as measured by MitoSOX Red (Figure 4A) and
exhibited a diminished oxygen consumption rate (OCR) (Fig-
ure S4A). Surprisingly, these cells possessed a normal quantity
of mitochondria, normal mitochondrial membrane potential,
and a normal rate of glycolysis as determined by the ECAR
(Figures S4B–S4D). Thus, we expected Uqcrfs1/ T cells to
specifically lack mitochondrial complex III ROS and mitochon-
drial production of ATP (oxidative phosphorylation), but not all
mitochondrial function, such as orchestration of cell death. In
fact, there was no change in cell viability after 24 hr of cell culture
between WT CD4+ T cells and Uqcrfs1/ CD4+ T cells (Fig-
ure S4E). However, Uqcrfs1/ CD4+ T cells failed to induce228 Immunity 38, 225–236, February 21, 2013 ª2013 Elsevier Inc.IL-2 (Figure 4C) and had reduced expression of activation
markers CD69 and CD25 (Figure 4B) when stimulated with
anti-CD3 and anti-CD28. Importantly, IL-2 induction was
rescued by treatment with GaO and Gal (Figure 4C), which indi-
cates that H2O2 derived from complex III is required for IL-2
induction. Further, IL-2 induction was also rescued by stimula-
tion with PMA and ionomycin (Figure 4D), which induced
mROS production (most likely at complexes I and II) to an
amount comparable to that of stimulation of WT T cells with
anti-CD3 and anti-CD28 (Figure 4E). IL-2 induction by PMA
and ionomycin in Uqcrfs1/ T cells was sensitive to MVE (Fig-
ure 4D), further indicating that PMA and ionomcyin stimulation
could compensate for the lack of complex III ROS by inducing
ROS through complexes I and II. Thus, complex III ROS are
required for IL-2 induction and T cell activation.
IL-2 induction necessitates activation of the mitogen-acti-
vated protein kinase (MAPK) pathway, which has been reported
to be redox sensitive (Kamata et al., 2005). However, we found
that phosphorylation of extracellular-signal-regulated kinases 1
and 2 (ERK1/2) was intact after CD3 and CD28 stimulation of
Uqcrfs1/ T cells (Figure S4F). Multiple reports also suggest
Figure 3. Uqcrfs1fl/fl; Cd4-cre Mice Have Reduced Expression of RISP in T Cells
(A) Total number of cells isolated from mouse thymuses (n = 5 ± SEM).
(B) Surface expression of CD4 and CD8 in mouse thymus (n = 5 ± SEM).
(C) RISP expression in purified CD4+ splenic T cells and total splenocytes from Uqcrfs1fl/fl and Uqcrfs1fl/fl; Cd4-cre mice (n = 4).
(D) Total number of splenocytes (after RBC lysis), B cells (CD45+B220+), macrophages (CD45+F4/80+), CD4+ T cells (CD45+CD4+), and CD8+ T cells (CD45+CD8+)
in Uqcrfs1fl/fl and Uqcrfs1fl/fl; Cd4-cre spleens (n = 5–7 ± SEM). ***p < 0.001.
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Mitochondrial ROS Regulate T Cell Activationthat NF-kB requires ROS for activation (Morgan and Liu, 2011);
however, phosphorylation of IkB appeared normal in the
Uqcrfs1/ T cells (Figure S4G). Instead, we found that NFAT
activation was defective in the Uqcrfs1/ T cells—although
Uqcrfs1/ cells expressed similar quantities of cytosolic
NFAT1, they failed to induce translocation of NFAT1 to the
nucleus upon CD3 and CD28 stimulation (Figure 4F). To confirm
this, we performed chromatin immunoprecipitation and found
that NFAT1 failed to bind the IL-2 promoter upon CD3 and
CD28 stimulation in Uqcrfs1/ cells (Figure S4H). As expected,
PMA and ionomycin stimulation rescued NFAT1 nuclear translo-
cation in Uqcrfs1/ cells (Figure S4I). Expression of the NFAT-
dependent, activation-induced il3 was diminished in Uqcrfs1/
T cells similarly to IL-2, whereas expression of the NFAT-inde-
pendent, activation-induced myc was unchanged (Figures S4J
and S4K). Therefore, complex III ROS are required for NFAT
activation.
NFAT is activated by dephosphorylation by calcineurin, which
allows it to translocate to the nucleus and function as a transcrip-
tion factor. Calcineurin is dependent on calcium and calmodulin;
therefore, we wanted to determine whether the CRAC channel
was functional in the Uqcrfs1/ cells. We found that release of
intracellular calcium stores by IP3-dependent calcium channels
was normal in the Uqcrfs1/ cells (Figure 4G, arrow), indicating
that assembly and activation of the upstream TCR complex is
intact in these cells. CRAC-channel activation was also intact
(Figure 4G), which supports the finding that calcium influx
through CRAC channels is upstream of mROS induction in
T cell activation. This suggests that in T cell activation, calcium
plays multiple roles, including activation of calcineurin through
calmodulin and stimulation of mROS. Together, these data indi-
cate that mitochondrial complex III ROS are required for CD4+
T cell activation through NFAT in vitro.Mitochondrial Complex III ROS Are Required for
Antigen-Specific CD4+ T Cell Expansion In Vivo
Uqcrfs1/CD4+ T cells did not proliferate in vitro upon CD3 and
CD28 stimulation or PMA and ionomycin stimulation, even with
the addition of recombinant IL-2 (Figure S5). This wasmost likely
due to an inability to generate biosynthetic intermediates that
require an intact TCA cycle for their synthesis, but not due to
a lack of CD25 (IL-2 receptor) surface expression, given that
CD25 was reduced but not absent (Figure 4B). To determine
whether Uqcrfs1/ CD4+ T cells could proliferate in vivo, we
measured homeostatic expansion of purified Uqcrfs1fl/fl or
Uqcrfs1/ CD4+ T cells in Rag1-deficient mice. Surprisingly,
the Uqcrfs1/ cells had no defect in homeostatic expansion
(Figure 5A), suggesting that these cellsmet their ATP and biosyn-
thetic demands necessary for proliferation in the in vivo environ-
ment. However, when we coinjected Uqcrfs1fl/fl or Uqcrfs1/
T cells with congenic WT T cells, we found that under competi-
tive conditions, Uqcrfs1/ T cells did not proliferate as well as
Uqcrfs1fl/fl T cells (Figure 5B). Interestingly, T-Uqcrfs1/ mice
possessed more naive CD4+CD62L+CD44 cells and fewer acti-
vated CD4+CD62LCD44+ cells than did their littermate controls
(Figure 5C). This suggests that theUqcrfs1/CD4+ T cells might
possess a defect in activation and antigen-specific, TCR-depen-
dent proliferation, which could explain the decrease in abun-
dance. To test this possibility, we immunized mice with the
lymphocytic choriomeningitis virus (LCMV) peptide GP61 (amino
acids 61–80 in the glycoprotein) in complete Freund’s adjuvant
(CFA) and used major histocompatibility complex (MHC) class
II I-Ab LCMV GP61 tetramers to measure expansion of GP61-
specific CD4+ T cells after 6 days (Wojciechowski et al., 2006).
Whereas GP61-specific CD4+ T cells were observed in WT
T cells, the T-Uqcrfs1/ mice failed to induce expansion of
GP61-specific CD4+ T cells (Figure 5D). These data indicateImmunity 38, 225–236, February 21, 2013 ª2013 Elsevier Inc. 229
Figure 4. Mitochondrial Complex III ROS Are Required for Antigen-Specific CD4+ T Cell Expansion
(A) mROS production measured by MitoSOX Red fluorescence after CD3 and CD28 stimulation (n = 3 ± SEM). *p < 0.05.
(B) Surface expression of CD69 and CD25 in CD4+ T cells isolated from Uqcrfs1fl/fl and Uqcrfs1fl/fl; Cd4-cre mice (n = 3 ± SEM).
(C) Relative IL-2 mRNA expression, normalized to ML-19 expression, of CD4+ T cells isolated from Uqcrfs1fl/fl and Uqcrfs1fl/fl; Cd4-cremice stimulated with anti-
CD3 and anti-CD28 with and without treatment with GaO (0.045 U/ml) and Gal (500 mM) (n = 2 ± SEM). p < 0.05, **p < 0.01.
(D) Relative IL-2 mRNA expression, normalized to ML-19 expression, of CD4+ T cells isolated from Uqcrfs1fl/fl and Uqcrfs1fl/fl;Cd4-cremice stimulated with PMA
and ionomycin with and without treatment with MVE (1.5 mM) (n = 3 ± SEM). **p < 0.01.
(E) mROS production measured by MitoSOX Red fluorescence (n = 4 ± SEM). *p < 0.05.
(F) Nuclear and cytosolic NFAT1 levels measured by isolation of nuclear and cytosolic lysates and then by immunoblot (n = 3).
(G) Intracellular calcium concentration measured by Fura2-AM. Cells were transferred from 2mM calcium Ringer solution to 0 mM calcium solution with 10 mg/ml
anti-CD3 for stimulation of intracellular-store release (arrow). Cells were then transferred to 2mM calcium for store-operated calcium influx (CRAC channel influx)
to occur (n = 3).
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Mitochondrial ROS Regulate T Cell Activationthat RISP is required for antigen-specific expansion of CD4+
T cells in vivo. Because the Uqcrfs1/ CD4+ T cells were
capable of undergoing lymphopenia-induced homeostatic
expansion in vivo, their deficiency in antigen-specific expansion
was most likely due to insufficient complex III ROS generation
required for T cell activation, but not to an inability to meet
biosynthetic or bioenergetic demands.
Mitochondrial Complex III ROS Are Required for
Antigen-Specific CD4+ T Cell-Dependent Inflammation
In Vivo
To determine whether deficiency of RISP in T cells would affect
progression of a CD4+-T-cell-dependent inflammatory disease,
we assessed the susceptibility of the T-Uqcrfs1/ mice to the
ovalbumin (OVA) model of allergic asthma. In brief, T-Uqcrfs1/
mice and littermate controls were sensitized and boosted with
a mixture of OVA in alum or PBS in alum, challenged 3 weeks
later with aerosolized OVA inhalation, and sacrificed for analysis230 Immunity 38, 225–236, February 21, 2013 ª2013 Elsevier Inc.of lung inflammation (Bryce et al., 2006). Lung inflammation in
this model is entirely dependent on CD4+ T cell function (Afshar
et al., 2008). As expected, we found that the T-Uqcrfs1/ mice
did not exhibit an eosinophilic infiltrate in the bronchoalveolar
lavage (BAL) fluid (Figure 6A) or signs of lung inflammation by
histology (Figure 6B). Furthermore, the Th2-associated cyto-
kines, interleukin-4 (IL-4), interleukin-5 (IL-5), and interleukin-13
(IL-13), were not increased in the lung tissue, as is typically
seen in this model (Figure 6C). We also noted that the
T-Uqcrfs1/ mice failed to induce production of OVA-specific
immunoglobulin E (IgE) (Figure 6D), a B cell process that requires
assistance from CD4+ T cells for activation and class switching.
To ensure that the T-Uqcrfs1/mice are capable of inducing
an allergic response when T cell participation is bypassed, we
administered recombinant IL-4 intratracheally for 3 days and
then assessed lung inflammation. We detected an eosinophilic
infiltration into the BAL fluid (Figure 6E), as well as inflammation
by histology (Figure S6), in the T-Uqcrfs1/mice. Therefore, the
Figure 5. Mitochondrial Complex III ROS Are Required for CD4+ Antigen-Specific CD4+ T Cell Expansion
(A) Cell proliferation on day 4 of CD4+ T cells isolated from Uqcrfsfl/fl or T-Uqcrfs/ mice and transferred into Rag1-knockout mice (n = 3).
(B) Cell proliferation on day 4 of CD4+ T cells isolated from Uqcrfsfl/fl or T-Uqcrfs/ mice and cotransferred with Thy1.1 CD4+ T cells into Rag1-knockout
mice (n = 3).
(C) Surface expression of CD62L and CD44 in CD4+ populations from Uqcrfsfl/fl or T-Uqcrfs/ spleens (n = 5 ± SEM).
(D) Expansion of GP61-specific CD4+ T cells 6 days after immunoprecipitation injection of GP61 peptide in CFA into Uqcrfs1fl/fl or Uqcrfs1fl/fl; Cd4-cre mice
(n = 4 ± SEM). *p < 0.05, **p < 0.01.
Immunity
Mitochondrial ROS Regulate T Cell Activationdefect in induction of allergic asthma in the OVA model in these
mice was due to dysfunctional CD4+ T cells, not dysfunction of
a downstream cell type. Together, these experiments suggest
that RISP is required for expansion of antigen-specific CD4+
T cells to promote lung inflammation.
Mitochondrial Complex III ROS Are Required for
Antigen-Specific CD8+ T Cell Expansion In Vivo
Given thatCd4-cre drives expression of Cre recombinase in both
CD4+ and CD8+ T cells during the double-positive phase of T cell
development and that we saw a decrease in numbers of CD8+
T cells in the spleen (Figure 3D), wewanted to determine whether
CD8+ T cells also require RISP for antigen-specific expansion
and function. To do this, we infected T-Uqcrfs1/ mice with
a sublethal dose of L. monocytogenes expressing OVA (LM-
OVA). Clearance of L. monocytogenes after infection ismediated
by T cells, and CD8+ T cells provide the most substantial contri-
bution to protective immunity (Pamer, 2004). After a primary
infection, antigen-specific H2-M3-restricted T cells reach peak
frequencies 5–6 days later, whereas MHC-class-Ia-restricted
T cells reach peak frequencies 7–8 days after inoculation (Cho
et al., 2011). Thus, we harvested splenic and hepatic leukocytes
7 days after infection and analyzed them by flow cytometry. Like
CD4+ T cells, the Uqcrfs1/ CD8+ T cells failed to undergo
antigen-specific expansion (Figure 7A). Furthermore, when
splenic and hepatic leukocytes were restimulated in vitro withOVA peptide257–264 or heat-killed LM, very few Uqcrfs1
/
CD8+ T cells produced interferon-g (IFN-g) (Figure 7B).
To see whether the Uqcrfs1/ CD8+ T cells could mount
a memory response, we reinfected mice with LM-OVA 1 month
after primary infection. We saw a robust induction of the OVA-
specific CD8+ T cells in the WT mice after 3 days but few in the
T-Uqcrfs1/ mice (Figure 7C). Although bacterial burden
following primary infection can be regulated by the innate
immune response, bacterial burden following secondary infec-
tion ismore dependent on thememory T cell response.We noted
that the bacterial burden in the spleen was greatly increased in
the T-Uqcrfs1/mice, suggesting ineffective immune response
and clearance of this secondary infection (Figure 7D). Thus, as
for CD4+ T cells, RISP is required for antigen-specific expansion
of CD8+ T cells.
DISCUSSION
Activated T cells have a very different metabolic profile from
naive T cells. Previous studies have highlighted the critical role
of increased glucose metabolism in T cell activation. In contrast,
this study highlights the critical role of increased mitochondrial
metabolism in T cell activation. Our results indicate that glucose
metabolism only becomes important during T cell proliferation.
Prior to proliferation, mitochondrial metabolism is sufficient to
support cell signaling for T cell activation. Importantly, our resultsImmunity 38, 225–236, February 21, 2013 ª2013 Elsevier Inc. 231
Figure 6. Mitochondrial Complex III ROS Are Required for Antigen-Specific CD4+ T Cell-Dependent Inflammation In Vivo
(A–D) Ova-immunized (OVA) or sham-immunized (PBS) Uqcrfs1fl/fl and Uqcrfs1fl/fl; Cd4-cre mice were exposed to OVA by inhalation, and airway inflammation
was assessed (n = 4 ± SEM, representative of two experiments).
(A) Cellular composition of BAL fluid.
(B) Representative histological lung sections stained with hematoxylin and eosin (H&E) or PAS. The scale bars represent 100 mm.
(C) Relative IL-4, IL-5, and IL-13 mRNA expression, normalized to b-actin expression, from homogenized lungs. *p < 0.05, **p < 0.01.
(D) Serum ova-specific IgE-antibody level determined by ELISA. *p < 0.05.
(E) Five micrograms of recombinant mouse IL-4 or PBS was administered intranasally for 3 days, and airway inflammation was assessed. Number of eosinophils
in BAL fluid (n = 5 ± SEM).
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Mitochondrial ROS Regulate T Cell Activationshow that mROS specifically derived from complex III are
required for CD4+ T cell activation in vitro and antigen-specific
CD4+ and CD8+ T cell expansion in vivo. We found that
Uqcrfs1/ T cells, which lack oxidative phosphorylation and
complex III ROS production, did not express IL-2 after CD3
and CD28 stimulation in vitro. Exogenous H2O2 produced by
the addition of GaO andGal rescued IL-2 induction inUqcrfs1/
cells, and treatment of WT T cells with a mitochondrial-targeted
antioxidant phenocopied Uqcrfs1/ T cells, indicating that
mROS, not oxidative phosphorylation, are necessary for T cell
activation in vitro. Moreover, Uqcrfs1/ T cells did not prolif-232 Immunity 38, 225–236, February 21, 2013 ª2013 Elsevier Inc.erate upon various antigen stimulations in vivo but retained the
ability to proliferate under lymphopenic conditions. Thus, these
cells do not possess major defects in bioenergetic or biosyn-
thetic pathways in vivo, and we can attribute their inability to
expand upon antigen stimulation in vivo to a lack of mROS for
T cell activation.
Historically, mROS were thought to be primarily cytotoxic by
directly damaging DNA, lipids, and proteins (Finkel and Hol-
brook, 2000). Recent studies have indicated that mROS are
not categorically harmful and that low levels of ROS are impor-
tant for healthy cell function (Sena and Chandel, 2012). This is
Figure 7. Mitochondrial Complex III ROS
Are Required for Antigen-Specific CD8+
T Cell Expansion
(A) Frequency of OVA/Kb-specific CD8+ T cells in
LM-infected Uqcrfs1fl/fl and Uqcrfs1fl/fl; Cd4-cre
mice. Uqcrfsfl/fl and T-Uqcrfs/ mice were in-
fected with rLM-OVA. On day 7 postinfection,
splenocytes and hepatic leukocytes were stained
with anti-TCRb, anti-CD8, and OVA/Kb dimer
and analyzed by flow cytometry (n = 5 ± SEM).
**p < 0.01.
(B) Frequency of OVA/Kb-specific, IFN-g–pro-
ducing CD8+ T cells in LM-infected Uqcrfs1fl/fl and
Uqcrfs1fl/fl; Cd4-cre mice. Splenocytes from the
indicated mice were harvested on day 7 after LM
infection and stimulated with either OVA peptide
or heat-killed LM (HKLM). Cells were stained for
CD8 expression and intracellular IFN-g and were
analyzed by flow cytometry (n = 5 ± SEM).
(C) Frequency of OVA/Kb-specific CD8+ T cells in
Uqcrfs1fl/fl and Uqcrfs1fl/fl; Cd4-cre mice after
a second LM infection. One month after primary
LM infection (23 103 cfu), mice were rechallenged
with 4 3 104 cfu rLM-OVA. On day 3 after
secondary infection, splenocytes and hepatic
leukocytes were harvested and stained with anti-
TCRb, anti-CD8, and OVA/Kb dimer and analyzed
by flow cytometry (n = 5 ± SEM). **p < 0.01.
(D) Bacterial burden in spleens of LM-infected
Uqcrfs1fl/fl and Uqcrfs1fl/fl; Cd4-cre mice on day 3
after secondary infection (n = 5 ± SEM). **p < 0.01.
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Mitochondrial ROS Regulate T Cell Activationbecoming clear in innate immunity, given that mROS appear to
be essential for a wide range of innate immune function,
including antiviral, antibacterial, and antiparasitic responses
(West et al., 2011b). For example, West et al. recently reported
that stimulation of cell-surface toll-like receptors (TLRs) leads
to an increase in mROS production that is needed for clearance
of Salmonella typimurium (West et al., 2011a). TLR signaling
through mROS appears to be important in human disease
because cells from individuals with TRAPS (tumor-necrosis-
factor-receptor-associated periodic syndrome) exhibit greater
responsiveness to LPS as a result of increased mROS produc-
tion (Bulua et al., 2011). Other studies have identified a critical
role for mROS in RIG-1-like receptor signaling (Tal et al., 2009)
and NLRP3 inflammasome activation (Zhou et al., 2011). TheImmunity 38, 225–236,present study suggests that adaptive
immune cells follow suit with innate
immune cells and also require mROS for
activation and function.
Our results suggest that mROS induc-
tion following CD3 and CD28 stimulation
of T cells is mediated by CD3-initiated
calcium signaling. We found that both
influx of calcium into the cytosol through
CRAC channels and influx of calcium
into the mitochondria are required for
mROS induction. Several TCA-cycle
enzymes, including pyruvate dehydroge-
nase and a-ketoglutarate dehydroge-
nase, are regulated by calcium (McCor-mack et al., 1990). Thus, we predict that calcium influx into
mitochondria increases TCA cycling and ETC flux and conse-
quently increases mitochondrial membrane potential and
mROS production. Indeed, we show here that mitochondrial
membrane potential is required for IL-2 induction through ROS.
Previous studies have shown that during T cell activation, mito-
chondria localize to the immunological synapse, where they
appear to regulate local calcium influx (Schwindling et al.,
2010). This localization would also allow for the efficiency of
short-lived ROS signals that are continually targeted for neutral-
ization by antioxidant proteins, such as superoxide dismutases,
catalases, glutathione, peroxiredoxins, among others.
We have identified the target of mROS to be downstream of
the CRAC channel and upstream of NFAT in the calcium,February 21, 2013 ª2013 Elsevier Inc. 233
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Mitochondrial ROS Regulate T Cell Activationcalcineurin, and NFAT pathway in T cell activation. Despite
precedents in the literature for ROS regulation of NF-kB and
MAPK activity, we found these pathways to be unaffected by
a lack of mitochondrial complex III ROS in the present system.
Given that we were able to rescue IL-2 induction in Uqcrfs1/
T cells within 24 hr by treatment with exogenous peroxide, we
suspect that mROS are required for a posttranslational protein
modification rather than alteration of protein expression. Future
studies will determine the specific mitochondrial complex III
ROS molecular target in T cell NFAT activation. It is possible
that mROS alter dephosphorylation of NFAT by calcineurin or
rephosphorylation of NFAT by kinases like GSK3b to regulate
the quantity of nuclear, active NFAT.
An important implication of this study is that therapeutic strat-
egies must consider the essential role of low levels of ROS in
normal physiology. We predict that antioxidant therapy or
supplements might prove to be detrimental during infection
because of the necessity of mROS for T cell activation.
Furthermore, this study promotes the viewpoint that cell
metabolism can regulate cell function. It is clear that T cells
engage in a specified or programmed change in metabolism
upon antigen stimulation and do not solely exhibit homeostatic
changes in metabolite flux dictated by increased demands
(Jones and Thompson, 2007). This programmed change in
metabolism anticipates metabolic requirements for progression
to a new cell fate. For maximal efficiency, we propose that a
readout of metabolism—mROS—feeds back and impinges on
signaling pathways to ensure cooperation of both cellular
signaling and cellular metabolism for important cell-fate deci-
sions. Thus, cellular metabolism is not merely a structured series
of reactions responsive only to energetic needs but is rather a
malleable, adaptive program that is highly integrated with cell
signaling. Our data indicate that mitochondria, classically known
as ‘‘the powerhouse of the cell,’’ are also signaling organelles
that play a critical role in the regulation of T cell activation.
EXPERIMENTAL PROCEDURES
Animal Experiments
Animal experiments were conducted in accordancewith Northwestern Univer-
sity’s institutional guidelines on the treatment of animals.
Oxygen Consumption, Extracellular Acidification, and ROS
Measurement
The OCR and ECARweremeasured with the Extracellular Flux Analyzer (XF24,
Seahorse Bioscience) according to themanufacturer’s protocol. MitoOCRwas
determined by the subtraction of OCR after treatment with 2 mM rotenone
(Sigma) and 2 mM antimycin (Sigma) from basal OCR. mROS production was
measured either by mito-roGFP fluorescence or by MitoSOX Red (Invitrogen)
fluorescence. For mito-roGFP experiments, CD4+ T cells were isolated from
spleens of mito-roGFP transgenic mice (gift from Paul Schumacker).
Mito-roGFPcontains twosurface-exposedcysteine residues that can formadi-
sulfide bond when oxidized by H2O2 or superoxide. Disulfide-bond formation
increases the excitation spectrum peak near 400 nm at the expense of the
peak near 490 nm. The ratios of fluorescence from excitation at 400 and
490nm indicate the extent of oxidation of theprobe and thus the redoxpotential
within the mitochondrial matrix. Cells were stimulated with anti-CD3 and anti-
CD28, and ratiometricmeasurementsof excitationwere taken. Themito-roGFP
probe was calibrated by treatment of cells with 1 mM dithiothreitol (DTT) for
complete reduction and with 1 mM t-butyl H2O2 for complete oxidation. The
percentage of oxidized probe was determined by the following formula: %
oxidized probe = (X – DTT) / (H2O2 – DTT). For MitoSOX Red experiments,234 Immunity 38, 225–236, February 21, 2013 ª2013 Elsevier Inc.5 mMMitoSOX Red in complete media was added to cells at 37C 15 min prior
to harvesting. Mean fluorescence intensity was measured by flow cytometry.
Homeostatic Expansion in Rag1-Deficient Mice
CD4+ T cells were purified and stained with carboxyfluorescein succinimidyl
ester (CFSE), and 2 3 106 cells were injected retroorbitally intravenously into
Rag1-deficient mice. Mice were sacrificed 4 days later, and spleens and
mesenteric lymph nodes were removed for analysis by flow cytometry. For
competitive homeostatic expansion, CD4+ T cells were purified from both
Thy1.1 mice (Jackson Laboratory) and Thy1.2, Uqcrfs1fl/fl, or Uqcrfs1fl/fl;
Cd4-cre mice, stained with CFSE, and coinjected (1:1 ratio; 2 3 106 cells
each) retroorbitally intravenously into Rag1-deficient mice.
GP61-Specific CD4+ Expansion
Six- to eight-week-old mice were immunized with 150 mg GP61 peptide in CFA
or CFA alone subcutaneously. Mice were sacrificed 6 days later, and spleens
and inguinal lymph nodes were removed for analysis by flow cytometry (Woj-
ciechowski et al., 2006). I-Ab-GP61 tetramer was a gift from David Hildeman.
OVA Immunization, Airway Inflammation, and Serum Antibody
Levels
Four- to eight-week-old female mice were sensitized to OVA by intraperitoneal
injection of 10 mgOVA (Grade VI; Sigma-Aldrich) in alum (3mg) or alum alone at
days 0 and 14. These mice were then challenged for 20 min with aerosolized
1% OVA by ultrasonic nebulization on days 21, 22, and 23 and were studied
on day 24. Mice were killed, and the lungs immediately flushed with 0.8 ml
BAL fluid (10% fetal calf serum, 1 mM EDTA, 31 PBS) via the trachea. Total
cells were counted, the remaining BAL fluid was cytospun onto slides, and
differential cell counts were performed after staining with DiffQuik (Baxter).
Tissue sections and histological staining were performed by Histo-Scientific
Research Laboratories. Serum was collected on day 24, and OVA-specific
IgE was determined by sandwich ELISA. OVA-specific IgE was determined
by comparison with a standard curve constructed with the use of purified
mouse OVA-specific IgE secreted by the hybridoma TOε.
Bacteria, Listeria Infections, and Colony Forming Unit Assays
The recombinant LM strain rLM-OVA was grown in brain-heart infusion broth
supplementedwith 5 mg/ml erythromycin. For primary infections, mice were in-
traobitally infected with 23 104 colony-forming units (cfu) of rLM-OVA. Recall
infection with 43 104 cfu rLM-ova was performed 1 month after primary infec-
tion. At the indicated times after infection, mice were sacrificed and bacterial
burden were determined (Dal Porto et al., 1993).
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